Palliative physician supports neuraxial analgesia for cancer pain

10/23/2012 | Medscape (free registration)

Neuraxial analgesia is an effective palliative care option for cancer patients with refractory pain or opioid toxicity, and it can be continued after discharge, according to Dr. Aynharan Sinnarajah, an intensive palliative care physician from Alberta, Canada. He told a palliative care conference that fentanyl and methadone are commonly used instead of first-line opioids and that patients often are on their third or fourth opioid drug before neuraxial analgesia is considered.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN